Predicting bortezomib-related severe neurologic adverse events by measuring proteasome activity in PBMCs.
Yukiko Cho(Ibaraki Prefectural Central Hospital), Daisuke Kudo(Barrow Neurological Institute), Mitsuo Hori(Ibaraki Prefectural Central Hospital), Ikuyo Ota(National Hospital Organization Mito Medical Center), Takuya Komeno(National Hospital Organization Mito Medical Center), Yukitaka Katsura(National Hospital Organization Mito Medical Center), Katsuhiro Sasaki(Kyoto University), Seiichi Shimizu(Tsuchiura Kyodo General Hospital), Hiroshi Kojima(Ibaraki Prefectural Central Hospital), Keiji Tanaka(Tokyo Metropolitan Institute of Medical Science), Yasushi Okoshi(Ibaraki Prefectural Central Hospital), Harumi Y. Mukai, Atsushi Shinagawa(Hitachi General Hospital), Chikashi Yoshida(National Hospital Organization Mito Medical Center)
Cited by 0
Related Papers
Autophagy regulates lipid metabolism
|Nature|2009|3.9k
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
|Nature Genetics|2000|2k
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
|The Journal of Cell Biology|2010|1.9k
Ubiquitin is phosphorylated by PINK1 to activate parkin
|Nature|2014|1.5k
The proteasome: Overview of structure and functions
|Proceedings of the Japan Academy Series B|2009|860